Market Overview

Baird Initiates Coverage on Gilead Sciences, Inc. at Outperform, Announces $86.00 PT

Share:

Get News First. Profit Faster

upsell-button
With Benzinga Professional get unlimited access to ALL content! PLUS:
  • REALTIME NEWSFEED
  • REALTIME AUDIO NEWS
  • FULL CALENDAR SUITE
  • CHAT WITH OUR NEWS DESK

Latest Ratings for GILD

DateFirmActionFromTo
Jan 2018Wells FargoUpgradesMarket PerformOutperform
Dec 2017Credit SuisseDowngradesOutperformNeutral
Nov 2017Maxim GroupUpgradesHoldBuy

View More Analyst Ratings for GILD
View the Latest Analyst Ratings

Posted-In: News Analyst Ratings

 

Related Articles (GILD)